NDC 50242-077 – Herceptin Hylecta
Trastuzumab 600 mg/5mL; Hyaluronidase (human Recombinant) 10000 U/5mL · Injection, Solution · Subcutaneous
Product NDC50242-077
Product details
- Brand name
- Herceptin Hylecta
- Generic name
- Trastuzumab and hyaluronidase-oysk
- Labeler
- Genentech, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761106
- Marketed since
- February 28, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Endoglycosidase; HER2/neu Receptor Antagonist
Active ingredients
- Trastuzumab 600 mg/5mL
- Hyaluronidase (human Recombinant) 10000 U/5mL
Uses, dosage, side effects and warnings for Herceptin Hylecta →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50242-077-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-077-01) / 5 mL in 1 VIAL, SINGLE-DOSE | Feb 28, 2019 |